Novo Nordisk takes on Pfizer in bid for obesity biotech Metsera | REUTERS

Denmark's Novo Nordisk launched a rival bid for US obesity biotech firm Metsera, hijacking an offer from Pfizer as the drugmakers jostled for advantage in the highly lucrative weight-loss drug market. #News #Reuters #Newsfeed #novonordisk #pfizer #metsera #weightlossdrugs Read the story here: https://reut.rs/47C2RHf 👉 Subscribe: http://smarturl.it/reuterssubscribe Keep up with the latest news from around the world: https://www.reuters.com/ Follow Reuters on Facebook: https://www.facebook.com/Reuters Follow Reuters on Twitter: https://twitter.com/Reuters Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en